期刊文献+

双镜联合微创技术运用于胃间质瘤治疗的临床效果观察 被引量:1

Clinical Effect of Double Endoscopy Combined with Minimally Invasive Technique in the Treatment of Gastric Stromal Tumor
下载PDF
导出
摘要 目的分析双镜联合微创技术运用于胃间质瘤治疗的临床效果。方法回顾分析北京市仁和医院2015年3月至2020年5月收治的胃间质瘤患者50例,按治疗方式分组,其中25例接受腹腔镜联合胃镜治疗,即双镜治疗(观察组),另25例接受腹腔镜治疗(对照组),比较治疗效果,如围术期指标、免疫功能等。结果观察组住院时间、术后进食时间、术中出血量、手术时间低于对照组,数据差异有统计学意义(P<0.05);比较住院时间,数据差异无统计学意义(P>0.05);观察组并发症总发生率12.00%低于对照组16.00%,数据差异无统计学意义(P>0.05)。结论临床治疗胃间质瘤可考虑采用腹腔镜联合胃镜的治疗方式,相比于单一腹腔镜手术来说,双镜治疗方式的有效性和安全性更高,可降低术中出血量和手术时间等,对术后病情恢复有利。 Objective To analyze the clinical effect of double endoscopy combined with minimally invasive technique in the treatment of gastric stromal tumor.Methods Fifty patients with gastric stromal tumor treated in Beijing Renhe Hospital from March 2015 to May 2020 were retrospectively analyzed.They were divided into two groups according to the treatment methods,25 patients were treated by laparoscopy combined with gastroscopy,namely double mirror treatment(observation group),the other 25 patients were treated by laparoscopy(control group).The therapeutic effects were compared,such as perioperative indicators,immune function,etc.Results The hospitalization time,postoperative eating time,intraoperative blood loss and operation time of the observation group were lower than those of the control group,and the difference was statistically significant(P<0.05).The difference was not statistically significant(P>0.05).The total incidence of complications of the observation group was 12.00%lower than that of the control group 16.00%,and the difference was not statistically significant(P>0.05).Conclusion The clinical treatment of gastric stromal tumor can consider the use of laparoscopy combined with gastroscopy.Compared with single laparoscopic surgery,double mirror treatment is more effective and safe,which can reduce intraoperative blood loss and operation time,and is beneficial to postoperative recovery.
作者 涂春明 董庆申 柳建垒 TU Chun-ming;DONG Qing-shen;LIU Jian-lei(Beijing Renhe Hospital,Beijing 102600)
机构地区 北京市仁和医院
出处 《智慧健康》 2021年第19期55-57,共3页 Smart Healthcare
关键词 腹腔镜 胃镜 胃间质瘤 免疫功能 病检 Laparoscopy Gastroscopy Gastric stromal tumor Immune function Pathological examination
  • 相关文献

参考文献13

二级参考文献123

  • 1黄平,周卫平,蔡国豪,王振奋.腹腔镜与开腹手术治疗胃肠间质瘤的疗效对比观察[J].中国急救医学,2018,38(A01):131-131. 被引量:3
  • 2沈琳.胃肠道间质瘤的诊断治疗进展[J].继续医学教育,2006,20(8):22-28. 被引量:1
  • 3Demetri GD, yon Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastro- intestinal stromal tumo [J]. J Natl Compr Canc Netw, 2010,8 (suppl 2):1-41.
  • 4Sepe PS, Moparty B, Pitman MB, et al. EUS-guided FNA for the diagnosis of GI stromal cell tumors: sensitivity and cytologic yield [ J ]. Gastrointest Endosc, 2009,70(2):254-261.
  • 5Eisenberg BL, Harris J, Blanke CD, et al. Phase II trim of neoad- juvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665 [J ]. J Surg On- col , 2009,99 ( 1 ):42-47.
  • 6Finre M, Palassini E, Fumagalli E, et al. Preoperative imatinib mesylate for unresectable or locally advanced primary gastroin- testinal stromal tumors (GIST) [J]. Eur J Surg Oncol, 2009,35 (7):739-745.
  • 7McAuliffe JC, Hunt KK, Lazar AJF, et al. A randomized, phase 1I study of preoperative plus postoperative imatinib in GIST: evi- dence of rapid radiographic response and temporal induction of tumor cell apoptosis [J]. Ann Surg Oneol , 2009, 16 (4): 910-919.
  • 8Blesius A, Cassier PA, Bertucci F, et al. Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the pro- spective BFR14 triM[J]. BMC Cancer, 2011,11:72.
  • 9Zalcberg JR, Verweij J, Casali PG, et al. Outcome of patients with advanced gastro-intestinal stromal tumours crossing over toa daily imatinib dose of 800 mg after progression on 400 mg[J]. EurJ Cancer, 2005,41 ( 12):1751-1757.
  • 10Demetri GD, van Oosterom AT, Garrett CR, et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stro- mal tumour after failure of imatinib: a randomised controlled trial [J]. Lancet, 2006,368(9544):1329-1338.

共引文献61

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部